Tetanus Toxoid (Tt) Vaccine 0.5 mL Suppliers & Bulk Manufacturers

Available Forms: Suspension for injection (single-dose and multi-dose vials)

Available Strengths: 0.5 mL

Reference Brands: Tetanus toxoid (adsorbed) vaccines; WHO-prequalified makers include Serum Institute of India

Category: Vaccines

Tetanus toxoid (TT) vaccine is an inactivated, adsorbed vaccine that protects against tetanus. It is given as a 0.5 mL intramuscular dose, including in pregnancy to protect newborns. Many programmes now use Td (tetanus and diphtheria) instead of TT, as WHO recommends. We quote from GMP-approved manufacturers and confirm document status, lead time and MOQ for each order.

Product Description:

Tetanus toxoid is tetanus toxin that has been made harmless with formaldehyde and adsorbed onto an aluminium salt. It cannot cause disease, but it teaches the immune system to make antibodies that neutralise the toxin produced by Clostridium tetani in contaminated wounds.

TT vaccine is given as a 0.5 mL intramuscular injection. It is used for primary immunisation and boosters, for wound management when protection is uncertain, and in pregnancy so that the mother's antibodies protect the newborn against neonatal tetanus. WHO recommends replacing TT with Td (tetanus plus reduced-dose diphtheria) so that diphtheria immunity is maintained, and many national programmes, including India's, have switched.

Sourcing notes. TT and Td vaccines are supplied in single-dose and multi-dose vials and need an unbroken 2–8 °C cold chain; they must not be frozen. UN agencies buy WHO-prequalified products, and national tenders usually ask for WHO prequalification or local registration plus lot release certificates. We confirm the product and documents for each tender.